Similar articles

• [Effects of intravenous perfusion of glucagon on plasma concentrations of glucose, insulin and cyclic AMP in patients with hepatic cirrhosis].

  Conde Yagüe R, Gutiérrez-Cortines Corral MD, Ledesma Castaño F, González Coterillo T, Valle Cagigas M, González Puerta C. Conde Yagüe R, et al. Rev Clin Esp. 1985 Oct;177(5):209-11. Rev Clin Esp. 1985. PMID: 3001846 Spanish. No abstract available.
• Glucagon-induced alterations of plasma levels of cyclic AMP and glucose in patients with liver disease.

  Klotz U, Antonin KH. Klotz U, et al. Z Gastroenterol. 1984 Mar;22(3):147-52. Z Gastroenterol. 1984. PMID: 6326401
• Anomalous adenosine cyclic 3':5'-monophosphate responses to glucagon in patients with hepatocellular carcinoma.

  Pun KK, Ho PW, Yeung RT. Pun KK, et al. Cancer Res. 1986 Apr;46(4 Pt 2):2152-4. Cancer Res. 1986. PMID: 3004721
• [Effect of glucagon on blood gastrin levels in hepatic cirrhosis: correlation with blood levels of cyclic AMP].

  Francavilla A, Sansonno D, Ierardi E, Amoruso A. Francavilla A, et al. Boll Soc Ital Biol Sper. 1980 Dec 30;56(24):2588-93. Boll Soc Ital Biol Sper. 1980. PMID: 6258616 Italian.
• Cyclic AMP metabolism and adenylate cyclase concentration in patients with advanced hepatic cirrhosis.

  Francavilla A, Jones AF, Starzl TE. Francavilla A, et al. Gastroenterology. 1978 Dec;75(6):1026-32. Gastroenterology. 1978. PMID: 213345 Free PMC article.